Back to Search Start Over

Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects

Authors :
He, Yan-Ling
Ligueros-Saylan, Monica
Sunkara, Gangadhar
Sabo, Ron
Zhao, Charlie
Campestrini, Joelle
Pommier, Francoise
Dole, Kiran
Marion, Alan
Dole, William P.
Howard, Dan
Source :
Journal of Clinical Pharmacology. January 2008, Vol. 48 Issue 1, p85, 11 p.
Publication Year :
2008

Abstract

Keywords: Dipeptidyl peptidase IV inhibitor; angiotensin converting enzyme inhibitor; angiotensin receptor blocker; calcium channel blocker; pharmacokinetics; type 2 diabetes; vildagliptin 85 Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No [...]

Details

Language :
English
ISSN :
00912700
Volume :
48
Issue :
1
Database :
Gale General OneFile
Journal :
Journal of Clinical Pharmacology
Publication Type :
Academic Journal
Accession number :
edsgcl.172567464
Full Text :
https://doi.org/10.1177/0091270007307880